General Information of the Compound
Compound ID
CP0012745
Compound Name
A-301
    Show/Hide
Synonyms
2(3H)-Benzoxazolone, 5-((2-((4-fluoro-3-methoxy-5-methylphenyl)amino)-5-methyl-4-pyrimidinyl)amino)-
5-((2-((4-Fluoro-3-methoxy-5-methylphenyl)amino)-5-methyl-4-pyrimidinyl)amino)-2(3H)-benzoxazolone
5-((2-(4-Fluoro-3-methoxy-5-methylphenylamino)-5-methylpyrimidin-4-yl)amino)benzo(d)oxazol-2(3H)-one
5-(2-(4-fluoro-3-methoxy-5-methylphenylamino)-5-methylpyrimidin-4-ylamino)benzo[d]oxazol-2(3h)-one
5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3H-1,3-benzoxazol-2-one
A-301
ATI-502
CHEMBL4594441
GTPL10638
Ifidancitinib [INN]
R105E71J13
SCHEMBL342002
UNII-R105E71J13
ifidancitinib
    Show/Hide
Structure
Formula
C20H18FN5O3
Molecular Weight
395.394
Canonical SMILES
COc1cc(Nc2ncc(C)c(Nc3ccc4oc(=O)[nH]c4c3)n2)cc(C)c1F
    Show/Hide
InChI
InChI=1S/C20H18FN5O3/c1-10-6-13(8-16(28-3)17(10)21)24-19-22-9-11(2)18(26-19)23-12-4-5-15-14(7-12)25-20(27)29-15/h4-9H,1-3H3,(H,25,27)(H2,22,23,24,26)
    Show/Hide
InChIKey
OYFMQDVLFYKOPZ-UHFFFAOYSA-N
CAS
1236667-40-5
Physicochemical Property
logP
4.16284
Rotatable Bonds
5
Heavy Atom Count
29
Polar Areas
105.07
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
7
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 46851625
SID: 99240675
ChEMBL ID
CHEMBL4594441
DrugBank ID
DB16191
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01214, Tyrosine-protein kinase JAK2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000251 Cheptage Homo sapiens (Human)  1
1
IC50 = 490 nM
   TI
   LI
   LO
   TS
CL000260 UKE-1 Homo sapiens (Human)  1
1
IC50 = 915 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( ATI-502 )
Drug Name ATI-502
Company Aclaris Therapeutics
Indication
Atopic dermatitis
Phase 2
Alopecia
Phase 2
Target(s)
Janus kinase 3 (JAK-3)
Inhibitor
Janus kinase 1 (JAK-1)
Inhibitor